{"id":173840,"date":"2026-08-10T08:58:02","date_gmt":"2026-08-10T08:58:02","guid":{"rendered":"https:\/\/pabau.com\/?p=173840"},"modified":"2026-08-17T07:23:59","modified_gmt":"2026-08-17T07:23:59","slug":"glp-1-statistics","status":"publish","type":"post","link":"https:\/\/pabau.com\/nl\/blog\/glp-1-statistics\/","title":{"rendered":"GLP-1 statistics: 65 numbers on usage, results and cost in 2026"},"content":{"rendered":"
\n
\n \"Key\n

Key takeaways<\/h3>\n <\/div>\n
\n
\n
\n \n \n <\/svg>\n <\/div>\n

12% of US adults are currently taking a GLP-1, and 18% have taken one at some point.<\/p>\n <\/div>\n

\n
\n \n \n <\/svg>\n <\/div>\n

GLP-1 prescribing per 100,000 US adults more than quadrupled between 2021 and 2026, from 1,884 to 8,819.<\/p>\n <\/div>\n

\n
\n \n \n <\/svg>\n <\/div>\n

Tirzepatide beat semaglutide head to head, with 20.2% average weight loss against 13.7% over 72 weeks.<\/p>\n <\/div>\n

\n
\n \n \n <\/svg>\n <\/div>\n

85% of people who start a GLP-1 for weight loss are no longer taking it two years later.<\/p>\n <\/div>\n

\n
\n \n \n <\/svg>\n <\/div>\n

Mounjaro and Zepbound together made $27.7 billion in the first half of 2026.<\/p>\n <\/div>\n

\n
\n \n \n <\/svg>\n <\/div>\n

Medicare’s negotiated semaglutide price is $274 a month from January 1, 2027, which is 71% below the previous list price.<\/p>\n <\/div>\n <\/div>\n <\/div>\n \n\n\n

Do you ever get the feeling that everyone is on Ozempic? According to our data, about one in eight US adults, or 12%, is currently taking a GLP-1 medication like Ozempic or Mounjaro1<\/a><\/sup>. Prescribing has more than quadrupled in under five years3<\/a><\/sup>, and the two leading brands earned $27.7 billion in six months28<\/a><\/sup>. Whatever corner of healthcare you work in, these drugs are reshaping it.<\/p>\n\n\n\n

Below, you’ll find 65 GLP-1 statistics that not only tell the story of an industry, but of millions of people struggling with obesity and diabetes across the United States. <\/p>\n\n\n\n

We’ll cover how many people take these drugs, their results, and how many people stop. We’ll also discuss what the medications cost and who pays, as well as the impact on the US med spa market<\/a>.<\/p>\n\n\n\n

A note on the facts:<\/strong> Every figure comes from a reputable and verified source. That means federal agencies, the survey houses that fielded the polls, peer-reviewed trials, and audited company results. The numbers are current as of August 2026.<\/p>\n\n\n\n

65 GLP-1 statistics and facts at a glance<\/h2>\n\n\n\n

Every statistic below sits in one of 11 sections. Use the list to jump straight to the number you need, or read on for the full picture.<\/p>\n\n\n\n